Articles From: Santarus and Pharming Announce Submission of RUCONEST Biologics License Application to FDA to Ingersoll Rand Announces Chief Financial Officer and General Counsel for New Security Company


2013/4/17
Santarus, Inc. (NASDAQ: SNTS) and Pharming Group NV (NYSE Euronext: PHARM) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RUCONEST ® (recombinant human C1 esterase inhibitor) 50 U/kg, an investigational drug for the treatment of acute angioedema attacks in patients with hereditary angioedema (HAE). The safety and efficacy of RUCONEST for the treatment of HAE attacks were evaluated in a clinical program that included a Phase III randomized placebo-controlled study conducted under a Special Protocol Assessment agreement with the FDA.
Sign-up for Santarus and Pharming Announce Submission of RUCONEST Biologics License Application to FDA investment picks
2013/4/17
NEW YORK , April 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating CIBER, Inc. (NYSE: CBR) , and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.
Sign-up for SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of CIBER, Inc. investment picks
2013/4/17
LAS VEGAS -- Hollywood studios and theater owners are rethinking the controversial idea of letting people pay extra to watch movies at home while they're still playing in theaters.
Sign-up for Studios, Theater Owners Mull New Ideas for Video On Demand investment picks
2013/4/17
TELUS two-for-one stock split completed Canada NewsWire Common shares commence trading on split basis today on TSX and NYSE VANCOUVER , April 17, 2013 /CNW/ - TELUS announced today that it has completed its previously announced two-for-one stock split of the company's common shares.
Sign-up for TELUS two-for-one stock split completed investment picks
2013/4/17
NEW YORK , April 17, 2013 /PRNewswire/ -- Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report first-quarter 2013 earnings on Thursday, April 18.
Sign-up for Verizon Communications to Report Earnings on April 18 investment picks
2013/4/17
OVERLAND PARK, Kan.
Sign-up for YRC Worldwide and International Association of Machinists Reach Tentative Agreement investment picks
2013/4/17
Comcast California to Mobilize 3,500 Employees, Family Members, Students and Parents in Nation's Largest Single-Day Corporate Volunteer Effort LIVERMORE, Calif.
Sign-up for 16 California Schools Impacted By Budget Cuts To Receive Volunteer Makeovers As Part Of 12th "Comcast Cares Day" investment picks
2013/4/16
Accenture (NYSE: ACN) launched a new Center of Excellence for Oracle Engineered Systems, hosted by the Accenture Innovation Centers for Oracle®, which will help enable faster and more cost-effective implementation of Oracle solutions for Accenture's clients globally.
Sign-up for Accenture Launches Center of Excellence Focusing on Oracle Engineered Systems investment picks
2013/4/16
Allergan, Inc. (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to its New Drug Application (NDA) for LEVADEX® (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
Sign-up for Allergan Receives Complete Response Letter from the U.S. Food and Drug Administration for LEVADEX® (dihydroergotamine) New Drug Application investment picks
2013/4/16
The U.S. Justice Department said it arrested an executive of French engineering company Alstom SA (ALO.FR) at New York's John F.
Sign-up for Alstom Executive Arrested in U.S. on Bribery Charges investment picks
2013/4/16
EMERYVILLE, Calif., April 16, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2013 after market close on Tuesday, April 30, 2013.
Sign-up for Amyris to Announce First Quarter Financial Results on Tuesday, April 30, 2013 investment picks
2013/4/16
Artisan Partners Asset Management Inc. (NYSE: APAM) will report its first quarter 2013 financial results on April 30, 2013 at approximately 4:15 p.m. (Eastern Time). Chief Executive Officer Eric Colson and Chief Financial Officer C.J. Daley will host a conference call at 5:00 p.m. (Eastern Time) to discuss the results.
Sign-up for Artisan Partners Asset Management Inc. to Announce 1Q13 Results on April 30, 2013 investment picks
2013/4/16
WAYNE, N.J. , April 16, 2013 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.
Sign-up for Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia investment picks
2013/4/16
New Common Core Program to Help Students and Teachers Meet More Rigorous Standards PITTSBURGH , April 16, 2013 /PRNewswire/ -- The Utah State Board of Education has approved Carnegie Learning Integrated Math I: A Common Core Program for purchase with state education funds designated for instructional materials.
Sign-up for Carnegie Learning® Common Core Integrated Math I Program Approved by Utah State Board of Education investment picks
2013/4/16
Dialogic Inc. (Nasdaq:DLGC) , the Network Fuel™ company , today announced that its common stock will begin trading on the OTCQB marketplace under the ticker symbol “DLGC” commencing Wednesday, April 17, 2013.
Sign-up for Dialogic Common Stock to Move to OTCQB from NASDAQ investment picks
2013/4/16
First Titan Corp.
Sign-up for FTTN to Commence Mergers & Acquisitions Search at Exclusive Event investment picks
2013/4/16
Investors Group announces changes to mutual funds impacted by the 2013 Federal Budget announcement Canada NewsWire WINNIPEG , April 16, 2013 /CNW/ - The 2013 federal budget proposed changes to Canadian tax laws that will impact the ability of investors to obtain tax-efficient exposure to a variety of investments.
Sign-up for Investors Group announces changes to mutual funds impacted by the 2013 Federal Budget announcement investment picks
2013/4/16
SAN DIEGO, April 16, 2013 (GLOBE NEWSWIRE) -- Lpath, Inc. (Nasdaq:LPTN) , the industry leader in bioactive lipid-targeted therapeutics, has added two key members to its leadership team.
Sign-up for Lpath Adds Two Key Members to its Executive Team investment picks
2013/4/16
http://media.marketwire.com/attachments/201111/41335_581026_MagnumLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1007509&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for Magnum Hunter Resources Provides First Quarter 2013 Company Wide Operational Update investment picks
2013/4/16
Pitney Bowes Inc. (NYSE:PBI) today announced the schedule for upcoming financial community events.
Sign-up for Pitney Bowes Announces Upcoming Financial Community Events investment picks
2013/4/16
SAN FRANCISCO (MarketWatch) -- Microsoft Corp.
Sign-up for PULSE: Microsoft rises as analyst sets overweight rating investment picks
2013/4/16
http://media.marketwire.com/attachments/201304/TN-145957_2012TractorwithPups.jpg Saia LTL Freight was recently named 'Carrier of the Year' by Ames True Temper.
Sign-up for Saia LTL Freight Named Carrier of the Year by Ames True Temper investment picks
2013/4/16
HOERSHOLM, Denmark , and SAN DIEGO , April 16, 2013 /PRNewswire/ -- Santaris Pharma A/S, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, today announced a worldwide strategic alliance with Bristol-Myers Squibb (NYSE: BMY) to discover and develop novel medicines using Santaris Pharma's proprietary Locked Nucleic Acid (LNA) Drug Platform.
Sign-up for Santaris Pharma announces a worldwide discovery alliance with Bristol-Myers Squibb for RNA-targeted medicines investment picks
2013/4/16
KNOXVILLE, Tenn.
Sign-up for Team Health Holdings Inc. Announces First Quarter 2013 Earnings Release Date and Conference Call investment picks
2013/4/16
The Coca-Cola Company today reported first quarter 2013 results.
Sign-up for The Coca-Cola Company Reports First Quarter 2013 Results investment picks
2013/4/16
Realty Income Corporation (Realty Income), The Monthly Dividend Company ® , (NYSE:O) , today announced that its Board of Directors has declared the 514 th consecutive common stock monthly dividend.
Sign-up for 514th Consecutive Common Stock Monthly Dividend Declared by Realty Income investment picks
2013/4/15
The ADT Corporation (NYSE: ADT) today announced the appointment of Alan D.
Sign-up for Alan D. Ferber Named ADT Chief Customer Officer investment picks
2013/4/15
At the 54 th Experimental NMR Conference (ENC), Bruker introduces new Ascend™ Aeon 600 and 700 superconducting, nitrogen-free magnet systems, which feature fully integrated Helium reliquefaction.
Sign-up for Bruker Introduces Actively Refrigerated Ascend™ Aeon Magnet Product Line investment picks
2013/4/15
Technology solutions and more than 70 products on display to showcase theme "Committed to Your Success.
Sign-up for Caterpillar Highlights Innovative Solutions for its Customers at bauma 2013 investment picks
2013/4/15
Ingersoll-Rand plc (NYSE:IR) is pleased to announce that Patrick Shannon will serve as senior vice president and chief financial officer, and Barbara Santoro will serve as senior vice president and general counsel for the new, standalone global security company to be created upon its separation from Ingersoll Rand later this year.
Sign-up for Ingersoll Rand Announces Chief Financial Officer and General Counsel for New Security Company investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Santarus and Pharming Announce Submission of RUCONEST Biologics License Application to FDA to Ingersoll Rand Announces Chief Financial Officer and General Counsel for New Security Company
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity